Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Current guidelines for the treatment of anaplastic astrocytoma (AA) recommend maximal safe resection followed by radiotherapy and chemotherapy. Despite this multimodal treatment approach, patients have a limited life expectancy. In the present study, we identified variables associated with overall survival (OS) and constructed a model score to pred...
Alternative Titles
Full title
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_84479185316047c39ec7b70b6af234b8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_84479185316047c39ec7b70b6af234b8
Other Identifiers
ISSN
1748-717X
E-ISSN
1748-717X
DOI
10.1186/s13014-020-01728-8
